Abbott | ABT

Stock Price
132.94
Daily Change
0.13 0.10%
Monthly
1.54%
Yearly
16.68%
Q3 Forecast
131.84

Peers Price Chg Day Year Date
Terumo 2,645.50 20.00 0.76% -0.02% Sep/05
Agilent 128.75 0.27 0.21% -6.04% Sep/05
Abbott 132.94 0.13 0.10% 16.68% Sep/05
AtriCure 35.38 -0.28 -0.79% 34.83% Sep/05
Baxter International 24.42 0.84 3.56% -37.34% Sep/05
Becton, Dickinson and Co. 192.39 1.13 0.59% -17.28% Sep/05
Bio-Rad Laboratories 295.43 6.00 2.07% -10.48% Sep/05
Boston Scientific 107.22 -0.07 -0.07% 31.36% Sep/05
Cooper Companies 68.09 0.09 0.13% -36.13% Sep/05
Danaher 200.21 1.18 0.59% -24.77% Sep/05
Dexcom 80.51 -0.25 -0.31% 17.11% Sep/05
Edwards Lifesciences 80.94 -0.02 -0.02% 21.19% Sep/05
Globus Medical 60.60 0.31 0.51% -13.42% Sep/05
Hologic 66.76 0.37 0.56% -18.16% Sep/05
Integra LifeSciences 15.99 0.34 2.17% -13.57% Sep/05
Intuitive Surgical 466.86 12.34 2.72% -1.06% Sep/05
J&J 178.43 -0.33 -0.18% 8.51% Sep/05
Masimo 147.19 4.18 2.92% 31.97% Sep/05
Medtronic 92.93 0.13 0.14% 3.32% Sep/05
Merit Medical Systems 92.97 0.82 0.89% -3.74% Sep/05
Pfizer 24.88 0.34 1.39% -12.95% Sep/05
Insulet 348.43 1.96 0.57% 62.25% Sep/05
Smith & Nephew 1,416.00 6.00 0.43% 18.15% Sep/05
Solventum Corp 72.72 0.34 0.47% 9.85% Sep/05
Stryker 392.31 -2.03 -0.51% 9.17% Sep/05
Teleflex 130.70 1.61 1.25% -46.61% Sep/05
Thermo Fisher Scientific 492.60 3.11 0.64% -19.59% Sep/05
Tandem Diabetes Care 12.58 0.19 1.53% -70.33% Sep/05
Zimmer Biomet Holdings 105.73 0.97 0.93% 0.76% Sep/05

Indexes Price Day Year Date
US500 6481 -20.59 -0.32% 19.84% Sep/05

Abbott traded at $132.94 this Friday September 5th, increasing $0.13 or 0.10 percent since the previous trading session. Looking back, over the last four weeks, Abbott gained 1.54 percent. Over the last 12 months, its price rose by 16.68 percent. Looking ahead, we forecast Abbott to be priced at 131.84 by the end of this quarter and at 128.58 in one year, according to Trading Economics global macro models projections and analysts expectations.

Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its products include a line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The Company’s products are sold directly to wholesalers, distributors, government agencies, health care facilities, pharmacies, and independent retailers from Abbott-owned distribution centers and public warehouses. It offers cardiovascular and metabolic products, including Lipanthyl, TriCor, Teveten, Teveten Plus, Physiotens, and Synthroid.